Approval for the gel-one.  The device is indicated for the treatment of pain in osteoarthritis (oa) of the knee in patients who have failed to respond adequately to non-pharmacologic therapy, non-steroidal anti-inflammatory drugs (nsaids) or analgesics, e. g., acetaminophen.